Thyromimetics
US11667606B2 · kind B2 · utility
0Cited by
29References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 27, 2020 |
| Grant date | Jun 6, 2023 |
| Priority date | — |
| Expiry date | Feb 27, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, X1, X2, Q, R1, R2 and n are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.